JPM fund exits from Celltrion

stock equities market_575px_adobe_6July20
By Rashmi Kumar
07 Jul 2020

One Equity Partners made its exit from Korea’s Celltrion Healthcare on Monday evening, cashing out of a stock that has rallied by about 97% over the past year.

Pharmaceutical company Celltrion listed in South Korea in mid-2017, when its shares were sold at W41,000 ($34.32) apiece. Fast forward three years, and it was trading at W107,500 a share when One Equity Partners hit the market on Monday.

One Equity Partners is a private equity firm spun out ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial